Gastrinoma
📧 Sign up to get email alerts when something new happens for Gastrinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: DOTATOC PET/CT for Imaging NET Patients
ClinicalTrials.gov entry describes a DOTATOC PET/CT imaging study for neuroendocrine tumors, sponsored by the British Columbia Cancer Agency…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the combination of everolimus and vatalanib in patients with advanced solid tumors, including several neuroendocrin…
-
FDA approval · 2024-07-09FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA granted supplemental approval for Octreotide Acetate from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.).
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating temozolomide with or without capecitabine in advanced pancreatic neuroendocrine tumors, including subtypes such as …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating regorafenib in advanced or metastatic neuroendocrine tumors has been completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating capecitabine, temozolomide, and bevacizumab for metastatic or unresectable pancreatic neuroendocrine tumors has com…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer [Phase 2]
Phase 2 study of temsirolimus in combination with bevacizumab in advanced endometrial, ovarian, liver, carcinoid, and pancreatic neuroendocr…
-
CLINICAL_TRIALS withdrawal · 2017-07-19Clinical Trial Update: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of dovitinib lactate for pancreatic neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid [Phase 2]
Phase 2 trial evaluating oral omeprazole and IV pantoprazole for hypersecretion of gastric acid in patients with gastrinoma and Zollinger-El…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer [Phase 2]
Phase 2 trial of pharmacokinetically guided everolimus in patients with breast cancer, pancreatic neuroendocrine tumors, or renal cell carci…
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Cixutumumab, Everolimus, and Octreotide acetate in patients with advanced low- to inter…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with progressive metastatic neuroendocrine tumors has completed; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update evaluating gefitinib in patients with progressive/metastatic neuroendocrine tumors has completed. The study en…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 trial of romidepsin for locally advanced or metastatic neuroendocrine tumors was terminated; the document lists the conditions studi…
-
CLINICAL_TRIALS trial_result · 2008-03-05Clinical Trial Update: Evaluating Patients With Abnormal Levels of Gastric Acid
The document reports the completion of an NIDDK clinical trial evaluating patients with abnormal gastric acid levels. It covers conditions s…